62052-77-1

Upstream product

• 62053-05-8 7-chloro-6-(2-chloroethyl)-5-methyl-1,2,4-triazolo<1,5-a>pyrimidine 
• 2393-23-9 4-methoxy-benzylamine 
• 74258-03-0 3-<<1-(tetrahydro-2-oxo-3-furyl)ethylidene>amino>-1,2,4-triazole 
• 62053-06-9 6-(2-hydroxyethyl)-5-methyl-1,2,4-triazolo<1,5-a>pyrimidin-7(4H)-one 
• 517-23-7 3-acetyl-2-oxo-4,5-dihydrofuran 

Downstream Products

• 74258-57-4 8-(4-Methoxy-benzyl)-5-methyl-8H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-a]pyrimidine 

Relevant academic research and scientific papers

Method of treating cachexia

Compounds of formula (I): STR1 and pharmaceutically acceptable salts thereof are valuable in the treatment of cachexia.

Studies on Cardiovascular Agents. 6. Synthesis and Coronary Vasodilating and Antihypertensive Activities of 1,2,4-Triazolopyrimidines Fused to Heterocyclic Systems

The synthesis and coronary vasodilating and antihypertensive activities of 1,2,4-triazolopyrimidines fused to pyrrole, thiophene, pyran, pyridine, and pyridazine are described.Among these compounds, 8-tert-butyl-7,8-dihydro-5-methyl-6H-pyrrolo3,2-

Pyrrolotriazolopyrimidine derivatives and process for the preparation thereof

Pyrrolotriazolopyrimidine derivatives having the formula STR1 wherein R1 represents hydrogen atom or an alkyl group having from 1 to 4 carbon atoms and R2 represents an alkyl group having from 1 to 4 carbon atoms, a cycloalkyl group